Status:
COMPLETED
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Lead Sponsor:
Sandoz
Conditions:
Psychosis
Eligibility:
MALE
35-55 years
Phase:
PHASE1
Brief Summary
To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
April 1 1987
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 1987
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00946491
Start Date
April 1 1987
End Date
May 1 1987
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.